에파비렌즈 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "에파비렌즈" in Korean language version.

refsWebsite

Global rank Korean rank

13web.archive.org

1^st place

10nih.gov

4^th place

7doi.org

2^nd place

3^rd place

4fda.gov

447^th place

433^rd place

3drugs.com

399^th place

141^st place

2bangkokpost.com

1,173^rd place

1,254^th place

1mfds.go.kr

low place

1,240^th place

1europa.eu

68^th place

145^th place

1handle.net

102^nd place

307^th place

1zenodo.org

621^st place

732^nd place

1cdc.gov

218^th place

52^nd place

1semanticscholar.org

11^th place

310^th place

1drugpatentwatch.com

low place

1indiadaily.com

low place

1books.google.com

3^rd place

9^th place

1iol.co.za

1,318^th place

4,525^th place

1bbc.co.uk

8^th place

34^th place

1go.com

48^th place

173^rd place

1youtube.com

9^th place

20^th place

bangkokpost.com

Wipatayotin, Apinya (2018년 11월 3일). “Thailand gets nod to make HIV/Aids drug”. 《Bangkok Post》. 2018년 11월 3일에 확인함.
APINYA WIPATAYOTIN (2018년 11월 3일). “Thailand gets nod to make HIV/Aids drug”. 《Thailand gets nod to make HIV/Aids drug》 (Bangkok Post).

bbc.co.uk

news.bbc.co.uk

Getting high on HIV drugs in S Africa. BBC News, 8 December 2008. 보관됨 9 12월 2008 - 웨이백 머신

books.google.com

Osewe, Patrick Lumumba; Korkoi Nkrumah, Yvonne; Sackey, Emmanuel K. (2008년 6월 15일). 《Improving Access to HIV/AIDS Medicines in Africa: Trade-Related Aspects of Intellectual Property Rights (TRIPS) Flexibilities Utilization》. World Bank Publications. 35–39쪽. ISBN 978-0-8213-7544-0. 2012년 6월 30일에 확인함.

cdc.gov

“Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States =” (PDF). Centers for Disease Control and Prevention. 2017년 1월 27일에 원본 문서 (PDF)에서 보존된 문서. 2016년 11월 7일에 확인함.

doi.org

dx.doi.org

Kuhar DT, Henderson DK, Struble KA, Heneine W, Thomas V, Cheever LW, 외. (September 2013). “Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis”. 《Infection Control and Hospital Epidemiology》 34 (9): 875–92. doi:10.1086/672271. PMID 23917901.
Waitt CJ, Garner P, Bonnett LJ, Khoo SH, Else LJ (July 2015). “Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studies”. 《The Journal of Antimicrobial Chemotherapy》 70 (7): 1928–41. doi:10.1093/jac/dkv080. PMC 4472329. PMID 25858354.
Rossi S, Yaksh T, Bentley H, van den Brande G, Grant I, Ellis R (May 2006). “Characterization of interference with 6 commercial delta9-tetrahydrocannabinol immunoassays by efavirenz (glucuronide) in urine”. 《Clinical Chemistry》 52 (5): 896–7. doi:10.1373/clinchem.2006.067058. PMID 16638958.
Röder CS, Heinrich T, Gehrig AK, Mikus G (June 2007). “Misleading results of screening for illicit drugs during efavirenz treatment”. 《AIDS》 21 (10): 1390–1. doi:10.1097/QAD.0b013e32814e6b3e. PMID 17545727.
Ren J, Bird LE, Chamberlain PP, Stewart-Jones GB, Stuart DI, Stammers DK (October 2002). “Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors”. 《Proceedings of the National Academy of Sciences of the United States of America》 99 (22): 14410–5. doi:10.1073/pnas.222366699. PMC 137897. PMID 12386343.
Treisman GJ, Soudry O (October 2016). “Neuropsychiatric Effects of HIV Antiviral Medications”. 《Drug Safety》 39 (10): 945–57. doi:10.1007/s40264-016-0440-y. PMID 27534750. S2CID 6809436.
Apostolova N, Funes HA, Blas-Garcia A, Galindo MJ, Alvarez A, Esplugues JV (October 2015). “Efavirenz and the CNS: what we already know and questions that need to be answered”. 《The Journal of Antimicrobial Chemotherapy》 70 (10): 2693–708. doi:10.1093/jac/dkv183. PMID 26203180.

drugpatentwatch.com

“Efavirenz Drug Profile”. 《DrugPatentWatch》. 2016년 11월 10일에 원본 문서에서 보존된 문서. 2016년 11월 9일에 확인함.

drugs.com

“Efavirenz”. The American Society of Health-System Pharmacists. 2016년 11월 17일에 원본 문서에서 보존된 문서. 2016년 11월 28일에 확인함.
“Merck & Co., Inc., Again Reduces Price of Stocrin (Efavirenz) for Patients in Least Developed Countries and Countries Hardest Hit by Epidemic”. 《Drugs.com MedNews》. 2014년 7월 14일에 원본 문서에서 보존된 문서.
“International brands for Efavirenz”. Drugs.com. 2016년 11월 10일에 원본 문서에서 보존된 문서. 2016년 11월 10일에 확인함.

europa.eu

ema.europa.eu

“Stocrin EPAR”. 《European Medicines Agency (EMA)》. 2020년 10월 15일에 확인함.

fda.gov

accessdata.fda.gov

“FDA-Sustiva”. 《FDA》. 2021.06.24에 확인함.
“FDA-Atripla”. 《FDA》. 2021.06.23에 확인함.
“Drug Approval Package: Sustiva (efavirenz) NDA# 20-972”. 《U.S. Food and Drug Administration (FDA)》. 2011년 12월 15일. 2020년 4월 25일에 확인함.
“Efavirenz: FDA-Approved Drugs”. 《U.S. Food and Drug Administration (FDA)》. 2020년 4월 25일에 확인함.

go.com

abcnews.go.com

'No Turning Back': Teens Abuse HIV Drugs. ABC News, April 6, 2009. 보관됨 4월 8, 2009 - 웨이백 머신

handle.net

hdl.handle.net

World Health Organization (2019). 《World Health Organization model list of essential medicines: 21st list 2019》. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

indiadaily.com

IndiaDaily - A new trend in emerging nations - Brazil opts for Indian generic drug ignoring US pharmaceutical giant Merck's patent on AIDS drug Efavirenz 보관됨 2008-02-19 - 웨이백 머신

iol.co.za

IOL: Thugs get high on stolen Aids drugs 보관됨 2013-08-06 - 웨이백 머신 IOL News May 12, 2007

mfds.go.kr

nedrug.mfds.go.kr

“식품의약품안전처-의약품안전나라-스토크린정600밀리그램”. 《식품의약품안전처-의약품안전나라》. 2021.06.24에 확인함.

nih.gov

ncbi.nlm.nih.gov

Kuhar DT, Henderson DK, Struble KA, Heneine W, Thomas V, Cheever LW, 외. (September 2013). “Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis”. 《Infection Control and Hospital Epidemiology》 34 (9): 875–92. doi:10.1086/672271. PMID 23917901.
Waitt CJ, Garner P, Bonnett LJ, Khoo SH, Else LJ (July 2015). “Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studies”. 《The Journal of Antimicrobial Chemotherapy》 70 (7): 1928–41. doi:10.1093/jac/dkv080. PMC 4472329. PMID 25858354.
Rossi S, Yaksh T, Bentley H, van den Brande G, Grant I, Ellis R (May 2006). “Characterization of interference with 6 commercial delta9-tetrahydrocannabinol immunoassays by efavirenz (glucuronide) in urine”. 《Clinical Chemistry》 52 (5): 896–7. doi:10.1373/clinchem.2006.067058. PMID 16638958.
Röder CS, Heinrich T, Gehrig AK, Mikus G (June 2007). “Misleading results of screening for illicit drugs during efavirenz treatment”. 《AIDS》 21 (10): 1390–1. doi:10.1097/QAD.0b013e32814e6b3e. PMID 17545727.
Ren J, Bird LE, Chamberlain PP, Stewart-Jones GB, Stuart DI, Stammers DK (October 2002). “Structure of HIV-2 reverse transcriptase at 2.35-A resolution and the mechanism of resistance to non-nucleoside inhibitors”. 《Proceedings of the National Academy of Sciences of the United States of America》 99 (22): 14410–5. doi:10.1073/pnas.222366699. PMC 137897. PMID 12386343.
Treisman GJ, Soudry O (October 2016). “Neuropsychiatric Effects of HIV Antiviral Medications”. 《Drug Safety》 39 (10): 945–57. doi:10.1007/s40264-016-0440-y. PMID 27534750. S2CID 6809436.
Apostolova N, Funes HA, Blas-Garcia A, Galindo MJ, Alvarez A, Esplugues JV (October 2015). “Efavirenz and the CNS: what we already know and questions that need to be answered”. 《The Journal of Antimicrobial Chemotherapy》 70 (10): 2693–708. doi:10.1093/jac/dkv183. PMID 26203180.

aidsinfo.nih.gov

“Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents”. 2016년 7월 14일. 2013년 5월 23일에 원본 문서에서 보존된 문서.
“Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection”. NIH AIDSinfo. 2016년 3월 1일. 2016년 11월 15일에 원본 문서에서 보존된 문서.
“Cost Considerations and Antiretroviral Therapy | Adult and Adolescent ARV Guidelines | AIDSinfo”. 《AIDSinfo》. 2016년 11월 17일에 원본 문서에서 보존된 문서. 2016년 11월 16일에 확인함.

semanticscholar.org

api.semanticscholar.org

Treisman GJ, Soudry O (October 2016). “Neuropsychiatric Effects of HIV Antiviral Medications”. 《Drug Safety》 39 (10): 945–57. doi:10.1007/s40264-016-0440-y. PMID 27534750. S2CID 6809436.

web.archive.org

“Efavirenz”. The American Society of Health-System Pharmacists. 2016년 11월 17일에 원본 문서에서 보존된 문서. 2016년 11월 28일에 확인함.
“Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents”. 2016년 7월 14일. 2013년 5월 23일에 원본 문서에서 보존된 문서.
“Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection”. NIH AIDSinfo. 2016년 3월 1일. 2016년 11월 15일에 원본 문서에서 보존된 문서.
“Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States =” (PDF). Centers for Disease Control and Prevention. 2017년 1월 27일에 원본 문서 (PDF)에서 보존된 문서. 2016년 11월 7일에 확인함.
“Efavirenz Drug Profile”. 《DrugPatentWatch》. 2016년 11월 10일에 원본 문서에서 보존된 문서. 2016년 11월 9일에 확인함.
“Cost Considerations and Antiretroviral Therapy | Adult and Adolescent ARV Guidelines | AIDSinfo”. 《AIDSinfo》. 2016년 11월 17일에 원본 문서에서 보존된 문서. 2016년 11월 16일에 확인함.
“Merck & Co., Inc., Again Reduces Price of Stocrin (Efavirenz) for Patients in Least Developed Countries and Countries Hardest Hit by Epidemic”. 《Drugs.com MedNews》. 2014년 7월 14일에 원본 문서에서 보존된 문서.
IndiaDaily - A new trend in emerging nations - Brazil opts for Indian generic drug ignoring US pharmaceutical giant Merck's patent on AIDS drug Efavirenz 보관됨 2008-02-19 - 웨이백 머신
IOL: Thugs get high on stolen Aids drugs 보관됨 2013-08-06 - 웨이백 머신 IOL News May 12, 2007
Getting high on HIV drugs in S Africa. BBC News, 8 December 2008. 보관됨 9 12월 2008 - 웨이백 머신
'No Turning Back': Teens Abuse HIV Drugs. ABC News, April 6, 2009. 보관됨 4월 8, 2009 - 웨이백 머신
Getting High On HIV Medication 보관됨 2014-04-11 - 웨이백 머신 Vice 7.04.2014.
“International brands for Efavirenz”. Drugs.com. 2016년 11월 10일에 원본 문서에서 보존된 문서. 2016년 11월 10일에 확인함.

youtube.com

Getting High On HIV Medication 보관됨 2014-04-11 - 웨이백 머신 Vice 7.04.2014.

zenodo.org

Kuhar DT, Henderson DK, Struble KA, Heneine W, Thomas V, Cheever LW, 외. (September 2013). “Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis”. 《Infection Control and Hospital Epidemiology》 34 (9): 875–92. doi:10.1086/672271. PMID 23917901.